BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7820545)

  • 1. Therapeutic trials in primary biliary cirrhosis.
    Sherlock S
    QJM; 1994 Nov; 87(11):701-3. PubMed ID: 7820545
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary biliary cirrhosis.
    Kaplan MM
    N Engl J Med; 1996 Nov; 335(21):1570-80. PubMed ID: 8900092
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined ursodeoxycholic acid plus colchicine--treatment of primary biliary cirrhosis: results of a placebo-controlled double-blind study].
    Raedsch R; Stiehl A; Walker S; Scherrmann JM; Kommerell B
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():55-7. PubMed ID: 1449019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary biliary cirrhosis.
    Gong Y; Christensen E; Gluud C
    N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
    [No Abstract]   [Full Text] [Related]  

  • 6. Reflections on therapeutic trials in primary biliary cirrhosis.
    Combes B
    Hepatology; 2005 Nov; 42(5):1009. PubMed ID: 16250047
    [No Abstract]   [Full Text] [Related]  

  • 7. Primary biliary cirrhosis: how should we evaluate new treatments?
    Goddard CJ; Warnes TW
    Lancet; 1994 May; 343(8909):1305-6. PubMed ID: 7910318
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
    Lotterer E; Fleig WE
    Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
    [No Abstract]   [Full Text] [Related]  

  • 9. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
    Lee YM; Kaplan MM
    Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
    Heathcote EJ; Cauch-Dudek K; Walker V; Bailey RJ; Blendis LM; Ghent CN; Michieletti P; Minuk GY; Pappas SC; Scully LJ
    Hepatology; 1994 May; 19(5):1149-56. PubMed ID: 8175136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: results of a controlled study].
    Leuschner U; Fischer H; Hübner K
    Z Gastroenterol Verh; 1989 Jul; 24():133. PubMed ID: 2474926
    [No Abstract]   [Full Text] [Related]  

  • 15. Reflections on therapeutic trials in primary biliary cirrhosis: a quality of life oriented counter-view.
    Jones DE; Bhala N; Newton JL
    Hepatology; 2006 Mar; 43(3):633; author reply 634. PubMed ID: 16496315
    [No Abstract]   [Full Text] [Related]  

  • 16. Medical treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1989 May; 9(2):138-43. PubMed ID: 2658104
    [No Abstract]   [Full Text] [Related]  

  • 17. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.
    González-Koch A; Brahm J; Antezana C; Smok G; Cumsille MA
    J Hepatol; 1997 Jul; 27(1):143-9. PubMed ID: 9252088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ursodeoxycholic acid therapy in primary biliary cirrhosis.
    Podda M; Crosignani A; Battezzati PM; Quagliuolo M; Valsania C; Invernizzi P; Zuin M
    Ital J Gastroenterol; 1996; 28(2):114-7. PubMed ID: 8782007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of primary biliary cirrhosis].
    Szalay F
    Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.